Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by JohnnyYegon Oct 20, 2023 12:46pm
147 Views
Post# 35693274

RE:RE:RE:Lets try & stay on topic, this is a great and detailed repor

RE:RE:RE:Lets try & stay on topic, this is a great and detailed repor

25 cents?? C'mon Foxy - that is ridiculous and uncalled for. As for Coffey, I will ask again, what is he supposed to do? If he is in negotations of anykind he can't report on anything. As far as any followup to PanCAN and the GOBLET trials, those are being presented at ESMO which have embargos on any new releases before the presentations. If there is anything to be "reported" on regarding the PDAC and CRC trials, if he drops any NR or comments, ONCY is out of ESMO for violating the embargo. 

All of this is perfect fodder for the MMs and shorties to take advantage of the SP, which they are doing - knowing Matt and ONCY's hands are tied. I'm willing to bet a nice juicy NR at the close of markets Monday - after the poster presentation in Madrid. Could possibly be before market opens since Madrid is 4 hours ahead of NY, EDT so the poster would have been public by that point (IF public is first thing in the morning Madrid time).

Hold tight folks, and for cripes sake let's all take a valium and calm down. 

<< Previous
Bullboard Posts
Next >>